1-4 of 4
Taofeek K. Owonikoko
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma

Conor E. Steuer, Christopher C. Griffith, Sreenivas Nannapaneni, Mihir R. Patel, Yuan Liu, Kelly R. Magliocca, Mark W. El-Deiry, Cynthia Cohen, Taofeek K. Owonikoko, Dong M. Shin, Zhuo G. Chen, Nabil F. Saba
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (3): 710–716.
https://doi.org/10.1158/1535-7163.MCT-17-0504
Published: 28 February 2018
View article titled, A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma
Open the PDF for A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract C49: Phase 1 study of CB-839, a first-in-class, orally administered small molecule inhibitor of glutaminase in patients with refractory solid tumors

Funda Meric-Bernstam, Angela DeMichele, Melinda L. Telli, Pamela Munster, Keith W. Orford, George D. Demitri, Gary K. Schwartz, Othon Iliopoulos, James W. Mier, Taofeek K. Owonikoko, Mark K. Bennett, Manish R. Patel, Jeffery R. Infante, James J. Harding
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): C49.
https://doi.org/10.1158/1535-7163.TARG-15-C49
Published: 01 December 2015
View article titled, Abstract C49: Phase 1 study of CB-839, a first-in-class, orally administered small molecule inhibitor of glutaminase in patients with refractory solid tumors
Journal Articles

Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non–Small Cell Lung Cancer

Rui Li, Zhongliang Hu, Shi-Yong Sun, Zhuo G. Chen, Taofeek K. Owonikoko, Gabriel L. Sica, Suresh S. Ramalingam, Walter J. Curran, Fadlo R. Khuri, Xingming Deng
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (10): 2200–2212.
https://doi.org/10.1158/1535-7163.MCT-13-0095
Published: 07 October 2013
View article titled, Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non–Small Cell Lung Cancer
Open the PDF for Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Rapamycin Induces Bad Phosphorylation in Association with Its Resistance to Human Lung Cancer Cells

Yan Liu, Shi-Yong Sun, Taofeek K. Owonikoko, Gabriel L. Sica, Walter J. Curran, Fadlo R. Khuri, Xingming Deng
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (1): 45–56.
https://doi.org/10.1158/1535-7163.MCT-11-0578
Published: 09 January 2012
View article titled, Rapamycin Induces Bad Phosphorylation in Association with Its Resistance to Human Lung Cancer Cells
Open the PDF for Rapamycin Induces Bad Phosphorylation in Association with Its Resistance to Human Lung Cancer Cells in another window
Includes: Supplementary data